Since transforming growth factor beta (TGF‐β) can act on CAFs to induce collagen production, one group showed that by administration of the TGF‐β inhibitor, SB431542, CAR‐T cell migration and cytotoxicity are restored against ovarian cancer cells.85 This evidence concerns the gene TGFB1 and ovarian carcinoma.